Analysis of patients with chronic lymphocytic leukemia (CLL) who discontinue BTK inhibitor monotherapy without disease progression.

OBSERVATIONAL STUDY WITH MEDICINES

Home · TEC24-Hematology and Gene Therapy Research Group: HemaTerGe

Clinical trial information

Sponsor: SPANISH CHRONIC LYMPHOCYTIC LEUKEMIA GROUP
Execution start: 30/10/24
End of execution: 28/02/25
IP: JOSE M PUERTA PUERTA